Skip to Content

3230 WPI (Meloxicam 7.5 mg)

Pill imprint 3230 WPI has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; rheumatoid arthritis; fibromyalgia; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Meloxicam 7.5 mg 3230 WPI
3230 WPI
7.5 mg
8.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
pregelatinized starch
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55289-0376 PDRX Pharmaceuticals Inc (repackager)
10544-0320 Blenheim Pharmacal Inc (repackager)
66336-0099 Dispensing Solutions Inc. (repackager)
18837-0239 Innoviant Pharmacy Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.